Hyderabad: Pfizer India on Monday announced the launch of ‘Open-AMR’, a free online platform to educate nurses on Antimicrobial Resistance (AMR) in English and other regional languages including Telugu. The Open-AMR initiative is a web-based platform that can be accessed by any nurse anywhere in India for free in seven different languages including English, Hindi, […]
Washington: Pfizer and its German partner BioNTech have said that preliminary clinical data showed their three-dose Covid-19 vaccine regimen was 80 per cent effective for children aged between 6 months to 5-years-old at preventing illness during the Omicron wave. The vaccine was found to elicit a strong immune response following a third dose, and was […]
Bengaluru: Predictive studies opine that the 4th wave of the Covid-19 will start in June-July and last till September, stated Karnataka Health Minister K. Sudhakar on Tuesday. “Karnataka is prepared to face it,” he added. He said that there is no need to worry as of now. The new XE variant of Covid-19 is prominent […]
Hyderabad: Continuing his efforts to get investments into Telangana, Industries Minister KT Rama Rao met senior officials of world’s largest pharma companies, including Pfizer, J&J and GSK in the United States on Friday. The three companies together represent more than 170 billions US dollars in annual revenue and the combined employee strength of these organizations […]
Hyderabad: Three pharma companies from Hyderabad have entered into agreement with UN-backed Medicines Patent Pool (MPP), headquartered in Geneva, to manufacture and supply a generic version of Pfizer’s Covid-19 oral treatment Nirmatrelvir. Aurobindo Pharma said it signed a sub-license agreement with MPP. Earlier, MPP signed voluntary licensing agreement with Pfizer for sub-licensing this Covid-19 treatment […]
Hong Kong: Despite low absolute risk, there is an increased relative risk of carditis — a type of heart inflammation — associated with Covid vaccine developed by US drugmaker Pfizer and China’s CoronaVac, researchers have found. The findings, published in Annals of Internal Medicine, show a significant increased risk in adolescents after the second dose. […]
London: A third ‘booster’ dose of Covid-19 vaccine successfully raises antibody levels that neutralise the Omicron variant, according to laboratory findings. Published as a research letter in The Lancet, researchers including from the Francis Crick Institute and UCLH Biomedical Research, found that antibodies generated in people who had received only two doses of either the […]
Washington: Pfizer said Tuesday that its experimental pill to treat COVID-19 appears effective against the omicron variant. The company also said full results of its 2,250-person study confirmed the pill’s promising early results against the virus: The drug reduced combined hospitalisations and deaths by about 89 per cent among high-risk adults when taken shortly after […]
Johannesburg: Pfizer’s mRNA-based Covid vaccine may be up to 40 times less effective against the new super mutant Omicron variant, a small study led by South African researchers have shown. The emergence of the Omicron variant of SARS-CoV-2 in November in South Africa has raised concerns that, based on the large number of mutations in […]
The global fears over the emergence of Omicron, the new and more virulent coronavirus variant, once again highlight an often neglected aspect of the pandemic: Vaccine inequality. The widening gulf between the rich and the poor nations in terms of inoculation coverage makes the fight against the virus less effective. Access to life-saving vaccines makes […]
